Stay updated on Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page’s revision tag changed from v3.6.2 to v3.6.3. This reflects a deployment/version update rather than a change to the page content.
    Difference
    0.1%
    Check dated 2026-07-03T22:00:02.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.2, replacing the previous v3.6.0. This indicates a newer revision of the page content and related materials.
    Difference
    0.1%
    Check dated 2026-06-26T23:46:11.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now includes new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the recruitment status to No longer looking for participants, indicating no current enrollment. A header formatting change and a revision label update are also present.
    Difference
    0.5%
    Check dated 2026-06-12T13:47:03.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.5.4 to v3.5.5, signaling a minor page-level update. No study content, eligibility criteria, or results information appear to have changed.
    Difference
    0.1%
    Check dated 2026-06-05T10:16:29.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    - The page revision label was updated to v3.5.4, replacing the previous v3.5.3 and signaling a minor update to the page without changing its study details.
    Difference
    0.1%
    Check dated 2026-05-14T22:55:35.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.2 to v3.5.3, representing a new version of the study record. This change signals a minor update to the page's versioning without altering the substantive study information.
    Difference
    0.1%
    Check dated 2026-04-30T16:36:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.